Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

The aim of the study was to evaluate the prognostic ability of the transcriptional profiling of the HER family genes in early breast cancer, as well as to investigate the predictive value of HER2 mRNA expression for adjuvant treatment with paclitaxel. RNA was extracted from 268 formalin-fixed paraff...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutras, A K, Kalogeras, K T, Dimopoulos, M-A, Wirtz, R M, Dafni, U, Briasoulis, E, Pectasides, D, Gogas, H, Christodoulou, C, Aravantinos, G, Zografos, G, Timotheadou, E, Papakostas, P, Linardou, H, Razis, E, Economopoulos, T, Kalofonos, H P, Fountzilas, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600696/
https://www.ncbi.nlm.nih.gov/pubmed/18985033
http://dx.doi.org/10.1038/sj.bjc.6604769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600696/
https://www.ncbi.nlm.nih.gov/pubmed/18985033
http://dx.doi.org/10.1038/sj.bjc.6604769

Ejemplares similares